ALVO
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$5.32
−1.12%Institutional positioning
13F filings over the trailing two quarters
New 17Increased 25Reduced 11Sold out 57
| Filer | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3,410,447 | May 15, 2026 |
| BRACEBRIDGE CAPITAL, LLC | Unchanged | 2,705,304 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 2,122,596 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 1,728,002 | Sep 2, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | 1,397,107 | May 15, 2026 |
| LITTLEJOHN & CO LLC | Unchanged | 1,318,534 | May 14, 2026 |
| BLACKROCK, INC. | Increased | 1,245,195 | May 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 974,228 | May 8, 2026 |
| LEGAL & GENERAL GROUP PLC | Reduced | 504,460 | May 8, 2026 |
| JPMORGAN CHASE & CO | Increased | 504,201 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 324,199 | May 15, 2026 |
| UBS GROUP AG | Increased | 322,157 | May 5, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 259,536 | Mar 25, 2026 |
| MORGAN STANLEY | Reduced | 243,277 | May 15, 2026 |
| OAKTREE CAPITAL MANAGEMENT LP | Reduced | 240,038 | May 20, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings